Encompass Health Corporation

Item 8.01. Other Events . On August 13, 2026, Encompass Health Corporation (the “Company”) completed the issuance and sale of $100 million in aggregate principal amount of its 5.875% Senior Notes due 2034 (the “Additional Notes”), along with the related guarantees of the Additional Notes by certain of the Company’s subsidiaries, in a private offering. The purchase price for the Additional Notes was 98.75% of the aggregate principal amount, resulting in net proceeds to the Company of approximately $96.9 million after deducting the initial purchasers’ discount and estimated offering expenses. The Company used the net proceeds from the sale of the Additional Notes, together with cash on hand, to repay a portion of the outstanding amounts under the Company’s revolving credit facility. The Additional Notes were sold to the initial purchasers in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), and will be resold by the initial purchasers to qualified institutional buyers in reliance on Rule 144A under the Securities Act and to non-U.S. persons in transactions outside the United States in reliance on Regulation S under the Securities Act. The terms of the Additional Notes are governed by the previously executed indenture, dated as of May 29, 2026 (the “Indenture”), by and among the Company, the subsidiary guarantors named therein, and Computershare Trust Company, National Association, as trustee. The Additional Notes represent a further issuance of the Company’s 5.875% Senior Notes due 2034, of which $500,000,000 aggregate principal amount was issued on May 29, 2026 (the “Existing Notes”) under the Indenture. Other than with respect to the date of issuance and public offering price, the Additional Notes have identical terms as the Existing Notes. The Additional Notes and the Existing Notes are treated as a single class for all purposes under the Indenture, including notices, consents, waivers, amendments, redemptions and any other action permitted under the Indenture, and rank pari passu with the Existing Notes.